GB1239266A - - Google Patents
Info
- Publication number
- GB1239266A GB1239266A GB1239266DA GB1239266A GB 1239266 A GB1239266 A GB 1239266A GB 1239266D A GB1239266D A GB 1239266DA GB 1239266 A GB1239266 A GB 1239266A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- forms
- analgesic
- inflammatory
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000000202 analgesic effect Effects 0.000 abstract 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 abstract 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 abstract 1
- APBSKHYXXKHJFK-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetic acid Chemical compound OC(=O)CC1=CSC(C=2C=CC(Cl)=CC=2)=N1 APBSKHYXXKHJFK-UHFFFAOYSA-N 0.000 abstract 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- 229910018626 Al(OH) Inorganic materials 0.000 abstract 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 1
- OMZRMXULWNMRAE-UHFFFAOYSA-N Vulpinicsaeure Natural products C=1C=CC=CC=1C(C(=O)OC)=C(C=1O)OC(=O)C=1C1=CC=CC=C1 OMZRMXULWNMRAE-UHFFFAOYSA-N 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 230000001458 anti-acid effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- FUFVKLQESJNNAN-RIMUKSHESA-M chembl1200851 Chemical compound [Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C)C(=O)C(O)C1=CC=CC=C1 FUFVKLQESJNNAN-RIMUKSHESA-M 0.000 abstract 1
- 229960003677 chloroquine Drugs 0.000 abstract 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 abstract 1
- 229960004126 codeine Drugs 0.000 abstract 1
- 229950011481 fenclozic acid Drugs 0.000 abstract 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 abstract 1
- 229960004369 flufenamic acid Drugs 0.000 abstract 1
- 229960003246 homatropine methylbromide Drugs 0.000 abstract 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 abstract 1
- CYWFCPPBTWOZSF-UHFFFAOYSA-N ibufenac Chemical compound CC(C)CC1=CC=C(CC(O)=O)C=C1 CYWFCPPBTWOZSF-UHFFFAOYSA-N 0.000 abstract 1
- 229950009183 ibufenac Drugs 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- 229960003464 mefenamic acid Drugs 0.000 abstract 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960000649 oxyphenbutazone Drugs 0.000 abstract 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960002895 phenylbutazone Drugs 0.000 abstract 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 abstract 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 abstract 1
- 229960005205 prednisolone Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- -1 uricosuric Chemical class 0.000 abstract 1
- 230000003424 uricosuric effect Effects 0.000 abstract 1
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
- NLQPTDHMZUGQCX-BMRADRMJSA-N vulpinic acid Chemical compound C=1C=CC=CC=1/C(C(=O)OC)=C(C1=O)\OC(O)=C1C1=CC=CC=C1 NLQPTDHMZUGQCX-BMRADRMJSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5707068 | 1968-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1239266A true GB1239266A (enExample) | 1971-07-14 |
Family
ID=10478283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1239266D Expired GB1239266A (enExample) | 1968-12-02 | 1968-12-02 |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1239266A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005019196A1 (en) * | 2003-08-11 | 2005-03-03 | Wyeth | 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
-
1968
- 1968-12-02 GB GB1239266D patent/GB1239266A/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005019196A1 (en) * | 2003-08-11 | 2005-03-03 | Wyeth | 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| US7495027B2 (en) | 2003-08-11 | 2009-02-24 | Wyeth | 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof |
| US7666904B2 (en) | 2003-08-11 | 2010-02-23 | Wyeth Llc | 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE37998B1 (en) | Indole derivatives | |
| ES8307494A1 (es) | "un procedimiento para preparar una composicion farmaceutica que proporciona un efecto anti-inflamatorio y analgesico junto con un dano gastrico minimizado". | |
| GB1146139A (en) | New 1-(3,5-dihalo-4-hydroxy-phenyl)-2-(aryloxy- or arylalkyl-isopropylamino)-propanols, process for their preparation and therapeutic composition containing same | |
| GB1290818A (enExample) | ||
| GB1307455A (en) | 2,-hydroxy-3-phenylpropiophenone derivatives | |
| GB1164510A (en) | Novel Isoxazole Derivatives, the preparation thereof, and Compositions containing the same | |
| GB1239266A (enExample) | ||
| IE32967B1 (en) | Novel thiazole derivatives,the preparation thereof and compositions containing the same | |
| GB1176757A (en) | Quinuclidine Carboxylic Acid Amides | |
| Miyazaki et al. | Solubility characteristics of weak bases and their hydrochloride salts in hydrochloric acid solutions | |
| GB1530074A (en) | Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents | |
| IE35569L (en) | 2-phenyl-5-aminodiazole derivatives | |
| GB1242863A (en) | 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF | |
| GB1460348A (en) | Quinazoline derivativesa | |
| ES8302623A1 (es) | "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico". | |
| GB1246117A (en) | Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture | |
| GB1268523A (en) | Dihydrofuran derivatives, the preparation thereof, and compositions containing the same | |
| GB1091109A (en) | New derivative of phenylbutazone and its preparation | |
| GB1397675A (en) | Proline compounds | |
| GB1390091A (en) | 4-4-biphenylyl-butyric acid derivatives | |
| GB1178724A (en) | Novel Quaternary Compounds | |
| GB1423089A (en) | Furopyrrole derivatives | |
| ES306804A1 (es) | Procedimiento para la obtencion de un compuesto quinolinico | |
| GB1217138A (en) | Pharmaceutical compositions based on derivatives of benzimidazole | |
| GB1190680A (en) | Halocinnamoyl Piperidines and Morpholines and Pharmaceutical Compositions Containing Them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |